NovaBay Pharma (NBY) Misses Q3 EPS by 18c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Other income (expense), net: -52K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Other income (expense), net: -52K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.34), $0.18 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $3.02 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
- EXL closes $1 billion credit facility, up from $600 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
